Evidence map›Paper›PMID 42506652›Full record

ArticleVaccines2026

Evaluation of Immunogenicity and Cross-Protective Efficacy of a CpG-Adjuvanted Trivalent Inactivated Influenza Vaccine in Ferrets.

Yanping Qiu, Yan Zhang, Shuangshuang He, Yutian Wang, Ruixin Wang, Yanxiao Han, Wen He, Eiketus Sho, Shaohua Han, Haojie Wu

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanping QiuHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Yan ZhangHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Shuangshuang HeHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Yutian WangHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Ruixin WangHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Yanxiao HanHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Wen HeJiangsu KMQ BioTech Inc., Nantong 226000, China.
Eiketus ShoJiangsu KMQ BioTech Inc., Nantong 226000, China.
Shaohua HanHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.
Haojie WuHuan Ke (Hebei) Biotechnology Co., Ltd., Shijiazhuang 050000, China.

Funding

Innovative Drug Research and Development National Science and Technology Major Project 2025ZD1804200
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CpG-TIVcross-protectionferret modelimmunogenicityprotective efficacy

Identifiers

PMID42506652
PMCPMC13418998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.